High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
Clinical trial NCT01334879 · COMPLETED
Trial details
- NCT number
- NCT01334879
- Sponsor
- The New York Eye Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.